The results confirmed that LCAT is significantly negatively correlated with MMR genes in BRCA, LIHC, PCPG, and PRAD tumors; LCAT is significantly positively correlated with MMR genes in ACC, GBM, OV, and UVM tumors (Figure 6D). Here, LCAT is linked to prostate adenocarcinoma.